Organized development from human embryonic stem cells after injection into immunodeficient mice.
about
Bioengineering kidneys for transplantationThe tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response.Early events in xenograft development from the human embryonic stem cell line HS181--resemblance with an initial multiple epiblast formationLessons from human teratomas to guide development of safe stem cell therapies.Defined culture conditions of human embryonic stem cells.Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors.Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cellsDirected differentiation of embryonic stem cells into bladder tissue.Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy.Embryonic stem cells in cardiac repair and regeneration.The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.Intrapancreatic Parenchymal Injection of Cells as a Useful Tool for Allowing a Small Number of Proliferative Cells to Grow In Vivo.Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.Teratoma generation in the testis capsule.Mesenchymal differentiation propensity of a human embryonic stem cell line.Derivation and cloning of a novel rhesus embryonic stem cell line stably expressing tau-green fluorescent protein.Recent highlights on bone stem cells: a report from Bone Stem Cells 2009, and not only….Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma.In vivo differentiation potential of buffalo (Bubalus bubalis) embryonic stem cell.Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.Tropism of the in situ growth from biopsies of childhood neuroectodermal tumors following transplantation into experimental teratoma.Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells
P2860
Q26864966-8C2819D5-5B95-40C8-89E7-1D44287CB3D7Q33350218-3D315205-D36A-4867-A11F-37F76302C84EQ34091050-8DC68B41-7C66-4F90-BD63-315484FE6C44Q34298868-A2B1D55A-ED39-41F3-B21E-0F687C817F9FQ34595854-373F8371-ECD3-44DF-9B15-CE7E48492FE6Q35127500-BDB68CD9-C078-4217-A5A7-494CA73E6CECQ35473934-CB9795E4-A18E-4C3B-8908-8C4561AA2D9DQ36013484-DC2FB0D6-AE2D-483E-8307-25EB3713F608Q36444328-5BA53C6B-E457-4180-A49D-DD3FCBFE57F4Q37388612-11042A76-6835-4FCF-B08E-9E09DF5F18C6Q37809765-3FADBD07-D7BD-43FB-8B0B-0C6FCDEBD2B2Q38287660-AF0CEAAC-5753-43F0-9A34-C32E070CD824Q38647092-8ACC5022-7427-47B2-8BA9-FAA8F768C7A0Q39262859-77DA49FE-8491-49F1-83D4-735F7559172DQ39430294-38AB62F8-33E0-4AA9-A0BD-0C15DFBA0124Q39576495-C48B1B4D-1508-4BAA-AD8D-A5DA24D51627Q39999958-0C587830-AD98-45FF-99D2-CD0286DC5C54Q41980898-39BB08D9-3554-41CD-9693-CB50E14DD7FFQ48226440-F4B4D847-F264-4FD9-8E12-A8263FDF2920Q48647292-A17FB7D1-7A48-41EF-8570-39B99754729AQ50628406-B62A6335-55D2-43CB-973C-F527C2117AE4Q52889077-3B29FB01-2DA8-4881-884D-302D7ABFDB1EQ55461443-52EEF15B-BBD2-45E1-96C2-2AB08DB6A146Q57817724-C5018C1B-FBD3-4C2B-AABD-8870E78ACB95
P2860
Organized development from human embryonic stem cells after injection into immunodeficient mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Organized development from hum ...... ion into immunodeficient mice.
@en
type
label
Organized development from hum ...... ion into immunodeficient mice.
@en
prefLabel
Organized development from hum ...... ion into immunodeficient mice.
@en
P2093
P50
P356
P1476
Organized development from hum ...... tion into immunodeficient mice
@en
P2093
Björn Rozell
Karin Gertow
Lars Ahrlund-Richter
Marta P Imreh
Mikael Wendel
P304
P356
10.1089/SCD.2004.13.421
P577
2004-08-01T00:00:00Z